[Federal Register: November 15, 2006 (Volume 71, Number 220)]
[Notices]
[Page 66533-66534]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15no06-71]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-0009]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
National Disease Surveillance Program I--Case Reports--Revision--
(OMB No. 0920-0009), National Center for Infectious Diseases (NCID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Formal surveillance of 19 separate reportable diseases has been
ongoing to meet the public demand and scientific interest in accurate,
consistent, epidemiologic data. These ongoing disease reports include:
Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob
Disease(CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-
lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease,
Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial
Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis.
Tularemia and Methicillin-Resistant Staphylococcus aureaus (MRSA) are
new additions to this submission. Case report forms from state and
territorial health departments enable CDC to collect demographic,
clinical, and laboratory characteristics of cases of these diseases.
This information is used to direct epidemiologic investigations,
identify and monitor trends in reemerging infectious diseases or
emerging modes of transmission, to search for possible causes or
sources of the diseases, and develop guidelines for prevention and
treatment. The data collected will also be used to recommend target
areas most in need of vaccinations for selected diseases and to
determine development of drug resistance.
Because of the distinct nature of each of the diseases, the number
of cases reported annually is different for each. There is no cost to
respondents other than their time. The total annual burden hours are
13,371.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number
Form Number of responses/ Total Hrs/response
respondents respondent responses
----------------------------------------------------------------------------------------------------------------
ABCs............................................ 329 21 6,909 10/60
ABCs Invasive MRSA.............................. 18 256 4,608 10/60
[[Page 66534]]
CJD............................................. 20 2 40 20/60
Cyclosporiasis.................................. 55 10 550 15/60
Dengue Case Investigation....................... 55 182 10,010 15/60
Hantavirus Pulmonary Syndrome................... 46 3 138 20/60
Idiopathic CD4+T-lymphocytopenia................ 10 2 20 10/60
Kawasaki Syndrome............................... 55 8 440 15/60
Legionellosis Case Report....................... 23 11.7 269 20/60
Lyme Disease Report............................. 52 385 20,020 10/60
Malaria Case Surveillance Report................ 55 20 1,100 15/60
Plague Case Investigation Report................ 55 0.20 11 20/60
Q Fever......................................... 55 1 55 10/60
Reye Syndrome Case Surveillance Report.......... 50 1 50 20/60
Tick-borne Rickettsial Disease Case Report...... 55 18 990 10/60
Trichinosis Surveillance Case Report............ 55 .45 25 20/60
Tularemia....................................... 55 2.2 121 20/60
Typhoid Fever Surveillance Report............... 55 6 330 20/60
Viral Hepatitis Case Record..................... 55 200 11,000 25/60
----------------------------------------------------------------------------------------------------------------
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-19263 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P